Abzena Recognized as Best Performing R&D Service Provider of the Year

One Nucleus has recognized Abzena as the “Best Performing R&D Service Provider of the Year”. The One Nucleus Awards are designed to celebrate life science companies focused on innovation equity and accessible, inclusive, and sustainable solutions.

Campbell Bunce, our Chief Science Officer shared: “Abzena’s core philosophy is generating maximum value for our customers with minimum risk to their projects.  A “start smart, finish fast” approach underpinned by extensive scientific and drug development expertise leads to a higher success rate for our customers through identifying and designing out liabilities before expensive manufacturing and clinical stages.  This is reflected in many dozens of our customers successfully securing series A funding, publicly listing, or being acquired by Pharma.  Overall, we’re focused on delivering the best possible experience for our customers, 85% of whom come back to us for additional work.”

Our Vice President of Scientific Operations, Nicole Wakes, accepted the award on our behalf the annual gala dinner. Other Abzena attendees included our Vice President of Research & Innovation, Rob Holgate, Head of EU/ROW Sales, Jonathan Cruickshank, and Vice President of Business Development, Roger Bowie.

Other nominees in our category included Cellomatics and o2h discovery. The winners were announced at One Nucleus’ annual black tie dinner ceremony focused on recognizing success in the life sciences community, which took place on Thursday, March 21^st.

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organization headquartered in Cambridge, UK. They support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity.